StockData
Abbott Laboratories logo

Abbott Laboratories (ABT) operating KPIs

ABTNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Jul 28, 2026Score 14/3036% above fair value
$106.20+1.63 (+1.56%)

Close on Oct 30, 2026Market cap $183.77BP/E 34.1Yield 2.26%

Abbott Laboratories reportable Segments Total Operating Earnings ($M) ($M)

Postgres DB segment_values + Form 10-K/10-Q Segment Footnote

QuarterlyAnnual
Latest, Q2 2026
1,693
Period ended Jun 30, 2026
Change on a year earlier
-17.5%
2,052 in Q2 2025
History
54 quarters
Since Q1 2013
Sources
41
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedReportable Segments Total Operating Earnings ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20261,693-17.5%SEC Filing (0001628280-26-050134) ↗
Q1 2026Mar 31, 20261,345-20.6%SEC Filing (0001628280-26-028357) ↗
Q4 2025Dec 31, 20252,251+17.8%SEC Filing (0001628280-26-010185) ↗
Q3 2025Sep 30, 20252,057+10.7%SEC Filing (0001628280-25-047131) ↗
Q2 2025Jun 30, 20252,052+22.9%SEC Filing (0001628280-26-050134) ↗
Q1 2025Mar 31, 20251,693+22.2%SEC Filing (0001628280-26-028357) ↗
Q4 2024Dec 31, 20241,911+7.4%SEC Filing (0001628280-26-010185) ↗
Q3 2024Sep 30, 20241,859+12.9%SEC Filing (0001628280-25-047131) ↗
Q2 2024Jun 30, 20241,669+8.2%SEC Filing (0001628280-25-036720) ↗
Q1 2024Mar 31, 20241,386-8.2%SEC Filing (0001628280-25-021090) ↗
Q4 2023Dec 31, 20231,780+36.5%SEC Filing (0001628280-26-010185) ↗
Q3 2023Sep 30, 20231,647-6.9%SEC Filing (0001628280-24-044602) ↗
Q2 2023Jun 30, 20231,542-35.1%SEC Filing (0001628280-24-033740) ↗
Q1 2023Mar 31, 20231,509-48.2%SEC Filing (0001628280-24-020011) ↗
Q4 2022Dec 31, 20221,304-45.2%SEC Filing (0001628280-25-007110) ↗
Q3 2022Sep 30, 20221,770-30.5%SEC Filing (0001628280-23-035957) ↗

Breakdown

What makes up reportable segments total operating earnings ($m)

Cite this data

StockData. (2026). Abbott Laboratories Reportable Segments Total Operating Earnings ($M) ($M), quarterly Q1 2013–Q2 2026 [Data set]. Compiled from Abbott Laboratories SEC filings and investor materials. https://stockdatahq.com/stocks/abt/kpis/db-seg-opinc-tot

See every metric in the Abbott Laboratories KPI table. Data updated Oct 29, 2026.